Pharmacy Certified Technician- Book test

Individuals eligible for both Medicaid and Medicare

pay no premium or deductivle and have no gap in coverage. They pay $1 per perscription for generics and $3 for brand names

Institutional pharmacy practice

may be defined as the provision of pateint-focused pharmacy services in a structured setting

Why are formularies designed

specify which medications a pharmacy will dispense, while inventory policies and procedures allow the pharmacy to properly account for its inventory and appropriately manage medications that require attention

formulary system

method for evaluating and selecting suitable drug products for an organized health setting

automatic interchange

substitutes one medication for another that is not generic equal but has a similar therapuetic and toxicologic effect

wholesalers

resell pharmaceuticals which have been purchased directly from the manufactureer to oharmacies, do not manufacture pharmaceuticals they are a distributing process

record completion

last part of purchasing process

borrowing pharmaceuticals

borrowing from one pharmacy to another is highly discouraged

investigational medicines

dispensing records and dose accountability are required

pharmacy compounding

refers to the task of preparing and packing a prescription order for a specific patient

TC graduate indicates

that the volume measured on the sacle is equal to the volume

reading a miniscus

bottom of the meniscus while holding the graduate at eye level

policy

describes what needs to be done and sets limits

what should documentation include

a record of who prepared the product, lot numbers, quantities of ingredients used, the assigned beyond-use date and any special storage requirements

Phase I: clinical investigation

clinnical investigation in a small number of pateints to determine the preferred route of administration and safe dosage

phase 2

limited number of patients for a specific disease treatment or prevention of disease to further determine drug's safety

phase 3

expanded to further test for safety and efficacy of the drug

phase 4

post-marketing surveillance continues after a drug is marketed. Manufacturer must report to FDA all serious adverse drug reactions, along with other info including additional drug safety data.